Skip to Content
Merck
CN

Medical therapy for acquired urinary incontinence in dogs.

International journal of pharmaceutical compounding (2012-10-18)
Katie Hill, Dinah Jordan, Jody Ray, Andrew A Mays, Katie Griffin
ABSTRACT

The objective of this case report was to review acquired canine urethral incontinence in a case of a 2-year-old beagle that presented for inappropriate urination. Commercially available medications, as well as compounded medical therapeutic options, were reviewed. Diagnostic results revealed cystitis, which responded to the prescribed antibiotics. The incontinence issue remained. Compounded diethylstilbestrol was prescribed and dispensed to achieve successful clinical results. The role of the compounding pharmacist was vital to achieve appropriate dosing of a drug no longer commercially available.

MATERIALS
Product Number
Brand
Product Description

Supelco
Diethylstilbestrol, VETRANAL®, analytical standard
Sigma-Aldrich
Diethylstilbestrol, ≥99% (HPLC)
Sigma-Aldrich
Estriol, meets USP testing specifications
Supelco
Estriol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®